Global Longlife Hospital and Research Limited is an India-based company, which is a multi-specialty tertiary care hospital. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gastrointestinal (GI) medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cardiovascular thoracic surgery (CVTS), joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery, ear, nose, and throat (ENT), plastic surgery, trauma center, urology, laparoscopic surgery, gynecology, and more. Its radiology services include mammography, CT scan, ultrasound, endoscopy, and sonography. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Global Longlife Hospital and R Financial Highlights
- Revenue: Global Longlife Hospital and R reported revenue of ₹0.01 crore in FY26 vs ₹5.60 crore in FY25. It showed a decrease of 99.82% on a yearly basis.
- Operating Profit: Global Longlife Hospital and R reported an operating loss of ₹0.99 crore in FY26 vs ₹0.10 crore in FY25. It showed a decrease of 1,090.00% on a year-on-year basis.
- Net Profit: Global Longlife Hospital and R reported a net loss of ₹1.72 crore in FY26 vs ₹0.20 crore in FY25. It showed a decrease of 960.00% on a yearly basis.
Global Longlife Hospital and R Quarterly Result Highlights
- Global Longlife Hospital and R reported revenue of ₹11.87 crore in Mar 2023, compared with ₹11.87 crore in Sep 2022, representing an increase of 0.00% on a quarter-on-quarter (QoQ) basis.
- Global Longlife Hospital and R reported an operating profit of ₹1.64 crore in Mar 2023, compared with ₹1.06 crore in Sep 2022, representing an increase of 54.72% on a quarter-on-quarter (QoQ) basis.
- Global Longlife Hospital and R reported a profit of ₹1.07 crore in Mar 2023, compared with ₹0.76 crore in Sep 2022, reflecting an increase of 40.79% on a QoQ basis.
- The earnings per share (EPS) of Global Longlife Hospital and R stood at ₹1.64 during Mar 2023.